Inventor · disambiguated record
Yu Tian Wang
Also filed as: WANG YU · WANG YU T · WANG YU TIAN
9 granted patents·9 pending applications·15 citations·filing 2004–2023
82Inventor score
Files withUNIV BRITISH COLUMBIA7CHEMOCENTRYX INC6WANG YU TIAN2QINGDAO PRIMEDICINE PHARMACEUTICAL COMPANY LTD1TAGHIBIGLOU CHANGIZ1
Top patents by PatentIndex Score
18 records- 0191US10532051B2Compositions and methods for treating inflammatory bowel disease using a combination therapy of small molecule inhibitors of C-C chemokine receptor 9 (CCR9) and anti-α4β7 integrin blocking antibodiesCHEMOCENTRYX INC·Filed 2015·Granted Jan 14, 2020·6 cites·7 claims
- 0287US11186620B2Peptide directed protein knockdownUNIV BRITISH COLUMBIA·Filed 2019·Granted Nov 30, 2021·4 cites·11 claims
- 0378US10287333B2Peptide directed protein knockdownUNIV BRITISH COLUMBIA·Filed 2013·Granted May 14, 2019·5 cites·14 claims
- 0472US2021322410A1Compositions and methods for treating inflammatory bowel disease using a combination therapy of small molecule inhibitors of c-c chemokine receptor type 9 (ccr9) and anti-alpha4beta7 integrin blocking antibodiesCHEMOCENTRYX INC·Filed 2021·Application pending·0 cites
- 0571US12428456B2Peptide directed protein knockdownUNIV BRITISH COLUMBIA·Filed 2021·Granted Sep 30, 2025·0 cites·8 claims
- 0663US2023382894A1Ccr4 antagonistsCHEMOCENTRYX INC·Filed 2023·Application pending·0 cites
- 0750US2010247540A1Methods and Compositions For Modulating AngiogenesisCHEMOCENTRYX INC·Filed 2009·Application pending·0 cites
- 0848US2010048653A1Neuroprotective modulation of nmda receptor subtype activitiesUNIV BRITISH COLUMBIA·Filed 2006·Application pending·0 cites
- 0948US2022362326A1Inhibiting zd17-jnk interaction as a therapy for acute myocardial infarctionUNIV BRITISH COLUMBIA·Filed 2020·Application pending·0 cites
- 1046US10258666B2Inhibitors of phosphatase and tensin homolog (PTEN) compositions, uses and methodsUNIV BRITISH COLUMBIA·Filed 2015·Granted Apr 16, 2019·0 cites·3 claims
- 1146US2006234912A1Methods for modulating neuronal responsesWANG YU T·Filed 2006·Application pending·0 cites
- 1245US2013045991A1Neuroprotective modulation of nmda receptor subtype activitiesUNIV BRITISH COLUMBIA·Filed 2012·Application pending·0 cites
- 1345US2005176073A1Cell proliferation associated with CCX CKR expressionCHEMOCENTRYX INC·Filed 2004·Application pending·0 cites
- 1443US9486472B2Methods for modulating neuronal responsesWANG YU TIAN·Filed 2011·Granted Nov 8, 2016·0 cites·6 claims
- 1541US11166924B2N-methyl-d-aspartate receptor allosteric modulators and methods for their useQINGDAO PRIMEDICINE PHARMACEUTICAL COMPANY LTD·Filed 2017·Granted Nov 9, 2021·0 cites·6 claims
- 1641US9127079B2Inhibitors of phosphatase and tensin homolog (PTEN) conjugatesWANG YU TIAN·Filed 2010·Granted Sep 8, 2015·0 cites·9 claims
- 1739US2005214287A1Methods and compositions for modulating angiogenesisCHEMOCENTRYX INC·Filed 2005·Application pending·0 cites
- 1838US11117939B2Polypeptides and antibodies to treat skin conditions associated with overproduction of sebumTAGHIBIGLOU CHANGIZ·Filed 2016·Granted Sep 14, 2021·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Yu Tian Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →